Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature
Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected....
Saved in:
Published in: | Indian journal of pathology & microbiology Vol. 64; no. 4; pp. 725 - 731 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
India
01-10-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM.
This is an observational retrospective study carried out in a single institute with patients registered between 1
January 2015 and 31
August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM.
Out of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up.
The study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management. |
---|---|
AbstractList | BACKGROUNDMultiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM. MATERIALS AND METHODSThis is an observational retrospective study carried out in a single institute with patients registered between 1st January 2015 and 31st August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM. RESULTSOut of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up. CONCLUSIONThe study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management. Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM. This is an observational retrospective study carried out in a single institute with patients registered between 1 January 2015 and 31 August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM. Out of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up. The study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management. |
Author | Mullapally, Sujith Kumar Digumarti, Leela Digumarti, Raghunadharao Nayak, Sonali Susmita Doni, Subhashreddy Vadgaonkar, Rohit Avinash |
Author_xml | – sequence: 1 givenname: Rohit Avinash surname: Vadgaonkar fullname: Vadgaonkar, Rohit Avinash organization: Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India – sequence: 2 givenname: Sonali Susmita surname: Nayak fullname: Nayak, Sonali Susmita organization: Department of Pathology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India – sequence: 3 givenname: Subhashreddy surname: Doni fullname: Doni, Subhashreddy organization: Department of Radiodiagnosis, SVS Medical College, Mahabubnagar, Telangana, India – sequence: 4 givenname: Leela surname: Digumarti fullname: Digumarti, Leela organization: Department of Gynecology, KIMS ICON Hospitals, Visakhapatnam, Andhra Pradesh, India – sequence: 5 givenname: Sujith Kumar surname: Mullapally fullname: Mullapally, Sujith Kumar organization: Department of Medical Oncology, Apollo Proton Cancer Center, Chennai, India – sequence: 6 givenname: Raghunadharao surname: Digumarti fullname: Digumarti, Raghunadharao organization: Department of Medical Oncology, KIMS ICON Hospitals, Visakhapatnam, Andhra Pradesh, India |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34673592$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkc1u1TAQha2qqP8PwAZ5yaIp_k1idlVboKgIFu068nUmxSixLx7nlr5UnxGHe0FsZmZxzpmxv2OyH2IAQl5zdqE4k-9uP3_7crGUjjOtO8H2yBEzjao0l2y_zLJpKmWEOSTHiD8Yq5XQ8oAcSlU3UhtxRF6uPWYfXKZrmzOkgDQONDo3pwTBwTl1cZpioBYxOm-zjwHPqQ09xTlt_MaOi6GYPYSM9Mnn7xTBxSJYJz_Z9EwnO_pHG5wHfE8vqa6ewSaKPjyOQH0o-_OcgcKvNSS_LN2mJNh4eFrSR18us3lOcEpeDXZEONv1E_Lw4eb-6lN19_Xj7dXlXeWENqyyvbFmYKZtuQNutYEGrFgBU0I1vVKa17WEgbtaNv2KCelKEW35Kt7qWq7kCXm7zV2n-HMGzN3k0cE42gBxxk7oVimpmZZFyrdSlyJigqHbvbtA6RZM3R9C_2Mqnje7-Hk1Qf_P8ZeL_A1bY5R7 |
CitedBy_id | crossref_primary_10_1002_cam4_7296 |
Cites_doi | 10.4103/0973-1482.65237 10.4103/0973-029X.86698 10.4103/0973-1482.183219 10.1097/00000658-196611000-00001 10.1097/CCO.0b013e32834bcc2a 10.1136/esmoopen-2017-000172 10.1007/s10552-013-0203-3 10.1016/S0194-59980300476-5 10.4103/2278-330X.179698 10.1007/s10549-018-4729-7 10.1186/1471-2407-14-272 10.2147/CMAR.S57378 10.1097/00000421-200302000-00015 10.1200/JCO.2011.38.2895 10.1016/j.ejca.2010.07.037 10.1634/theoncologist.12-1-20 10.4103/1319-3767.93823 10.4103/0973-1482.65241 10.1007/BF03215857 10.1158/1055-9965.EPI-11-0729 10.1001/jama.1921.02630200001001 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.4103/IJPM.IJPM_1055_20 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 0974-5130 |
EndPage | 731 |
ExternalDocumentID | 10_4103_IJPM_IJPM_1055_20 34673592 |
Genre | Journal Article Review |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- .55 29I 2WC 36B 53G 5GY 5VS 7X7 8FI 8FJ AAWTL ABDBF ABJNI ABUWG ABXLX ACGFO ACGFS ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR C1A CCPQU CGR CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBS ECM EIF EJD EMB EMK EMOBN EOJEC ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK IAO IEA IHR IL9 INH INR ITC KQ8 MM. M~E NPM OBODZ OK1 OVD PIMPY RMW SV3 TEORI TR2 TUS UKHRP X7M AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c2590-ad9a9f09881ce1a59e7ea2be04247d4451663ef1c637db023cb022849218563b3 |
ISSN | 0377-4929 |
IngestDate | Fri Aug 16 20:21:45 EDT 2024 Fri Nov 22 03:00:06 EST 2024 Sat Sep 28 08:23:43 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Multidisciplinary management multiple primary malignancies second primary |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2590-ad9a9f09881ce1a59e7ea2be04247d4451663ef1c637db023cb022849218563b3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://doi.org/10.4103/ijpm.ijpm_1055_20 |
PMID | 34673592 |
PQID | 2584435053 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2584435053 crossref_primary_10_4103_IJPM_IJPM_1055_20 pubmed_primary_34673592 |
PublicationCentury | 2000 |
PublicationDate | 2021 Oct-Dec 2021-10-00 20211001 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021 Oct-Dec |
PublicationDecade | 2020 |
PublicationPlace | India |
PublicationPlace_xml | – name: India |
PublicationTitle | Indian journal of pathology & microbiology |
PublicationTitleAlternate | Indian J Pathol Microbiol |
PublicationYear | 2021 |
References | Vaamonde (R10-17-20240829) 2003; 129 Etiz (R11-17-20240829) 2017; 13 Coyte (R12-17-20240829) 2014; 14 Coebergh (R17-17-20240829) 2010; 46 Hayat (R19-17-20240829) 2007; 12 Kumar (R4-17-20240829) 2010; 6 Owen (R9-17-20240829) 1921; 76 Hankey (R20-17-20240829) 1999; 8 Kollias (R25-17-20240829) 2001; 25 Bishen (R5-17-20240829) 2011; 15 Kushner (R24-17-20240829) 2018; 170 Demandante (R13-17-20240829) 2003; 26 Jena (R6-17-20240829) 2016; 5 Amer (R18-17-20240829) 2014; 5 Parry (R1-17-20240829) 2011; 20 Angurana (R3-17-20240829) 2010; 6 Spratt (R14-17-20240829) 1966; 164 Weir (R16-17-20240829) 2013; 24 Vogt (R8-17-20240829) 2017; 2 Leone (R21-17-20240829) 2011; 23 Lacouture (R22-17-20240829) 2012; 30 Rajalingam (R2-17-20240829) 2012; 18 Warren (R15-17-20240829) 1932; 16 Ricks (R23-17-20240829) 2015; 14 |
References_xml | – volume: 6 start-page: 230 year: 2010 ident: R3-17-20240829 article-title: Quadruple malignancy in a single patient: A case report and comprehensive review of literature publication-title: J Can Res Ther doi: 10.4103/0973-1482.65237 contributor: fullname: Angurana – volume: 15 start-page: 306 year: 2011 ident: R5-17-20240829 article-title: A case of dual malignancy: Presenting the necessity for extensive sampling for pathologic examination publication-title: J Oral Maxillofac Pathol doi: 10.4103/0973-029X.86698 contributor: fullname: Bishen – volume: 13 start-page: 16 year: 2017 ident: R11-17-20240829 article-title: Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey publication-title: J Cancer Res Ther doi: 10.4103/0973-1482.183219 contributor: fullname: Etiz – volume: 164 start-page: 775 year: 1966 ident: R14-17-20240829 article-title: Incidence of multiple primary cancers per man-year of follow up: 20-year review from the Ellis Fischel State Cancer Hospital publication-title: Ann Surg doi: 10.1097/00000658-196611000-00001 contributor: fullname: Spratt – volume: 23 start-page: 672 year: 2011 ident: R21-17-20240829 article-title: Therapy-related myeloid neoplasms publication-title: Curr Opin Oncol doi: 10.1097/CCO.0b013e32834bcc2a contributor: fullname: Leone – volume: 2 start-page: e000172 year: 2017 ident: R8-17-20240829 article-title: Multiple primary tumours: Challenges and approaches, a review publication-title: ESMO Open doi: 10.1136/esmoopen-2017-000172 contributor: fullname: Vogt – volume: 24 start-page: 1231 year: 2013 ident: R16-17-20240829 article-title: The effect of multiple primary rules on population-based cancer survival publication-title: Cancer Causes Control doi: 10.1007/s10552-013-0203-3 contributor: fullname: Weir – volume: 129 start-page: 65 year: 2003 ident: R10-17-20240829 article-title: Second primary malignancies in patients with cancer of the head and neck publication-title: Otolaryngol Head Neck Surg doi: 10.1016/S0194-59980300476-5 contributor: fullname: Vaamonde – volume: 16 start-page: 1358 year: 1932 ident: R15-17-20240829 article-title: Multiple primary malignant tumors. A survey of the literature and a statistical study publication-title: Am J Cancer contributor: fullname: Warren – volume: 5 start-page: 29 year: 2016 ident: R6-17-20240829 article-title: Multiple primary cancers: An enigma publication-title: South Asian J Cancer doi: 10.4103/2278-330X.179698 contributor: fullname: Jena – volume: 170 start-page: 45 year: 2018 ident: R24-17-20240829 article-title: Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-018-4729-7 contributor: fullname: Kushner – volume: 14 start-page: 222 year: 2015 ident: R23-17-20240829 article-title: Successes and challenges of PARP inhibitors in cancer therapy publication-title: Front Oncol contributor: fullname: Ricks – volume: 14 start-page: 272 year: 2014 ident: R12-17-20240829 article-title: Second primary cancer risk - the impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study publication-title: BMC Cancer doi: 10.1186/1471-2407-14-272 contributor: fullname: Coyte – volume: 5 start-page: 119 year: 2014 ident: R18-17-20240829 article-title: Multiple neoplasms, single primaries, and patient survival publication-title: Cancer Manag Res doi: 10.2147/CMAR.S57378 contributor: fullname: Amer – volume: 26 start-page: 79 year: 2003 ident: R13-17-20240829 article-title: Multiple primary malignant neoplasms publication-title: Am J Clin Oncol doi: 10.1097/00000421-200302000-00015 contributor: fullname: Demandante – volume: 30 start-page: 329 year: 2012 ident: R22-17-20240829 article-title: Induction of cutaneous squamous cell carcinomas by RAF inhibitors: Cause for concern? publication-title: J Clin Oncol doi: 10.1200/JCO.2011.38.2895 contributor: fullname: Lacouture – volume: 46 start-page: 2660 year: 2010 ident: R17-17-20240829 article-title: The long road towards cancer prevention: 4 steps backward and 8 forward publication-title: Eur J Cancer doi: 10.1016/j.ejca.2010.07.037 contributor: fullname: Coebergh – volume: 12 start-page: 20 year: 2007 ident: R19-17-20240829 article-title: Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program publication-title: Oncologist doi: 10.1634/theoncologist.12-1-20 contributor: fullname: Hayat – volume: 18 start-page: 143 year: 2012 ident: R2-17-20240829 article-title: Non-familial double malignancy of the colon and ampulla of vater: A case report and review of literature publication-title: Saudi J Gastroenterol doi: 10.4103/1319-3767.93823 contributor: fullname: Rajalingam – volume: 6 start-page: 227 year: 2010 ident: R4-17-20240829 article-title: Synchronous anaplastic oligodendroglioma and carcinoma tongue: A rare association publication-title: J Cancer Res Ther doi: 10.4103/0973-1482.65241 contributor: fullname: Kumar – volume: 25 start-page: 1117 year: 2001 ident: R25-17-20240829 article-title: Prognostic significance of synchronous and metachronous bilateral breast cancer publication-title: World J Surg doi: 10.1007/BF03215857 contributor: fullname: Kollias – volume: 8 start-page: 1117 year: 1999 ident: R20-17-20240829 article-title: The surveillance, epidemiology, and end results program: A national resource publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: Hankey – volume: 20 start-page: 1996 year: 2011 ident: R1-17-20240829 article-title: Cancer survivors: A booming population publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-11-0729 contributor: fullname: Parry – volume: 76 start-page: 1329 year: 1921 ident: R9-17-20240829 article-title: Multiple malignant neoplasm publication-title: JAMA doi: 10.1001/jama.1921.02630200001001 contributor: fullname: Owen |
SSID | ssj0064253 |
Score | 2.2918973 |
SecondaryResourceType | review_article |
Snippet | Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and... BACKGROUNDMultiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 725 |
SubjectTerms | Adolescent Adult Aged Child Female Head and Neck Neoplasms - complications Head and Neck Neoplasms - epidemiology Head and Neck Neoplasms - mortality Humans Incidence India - epidemiology Male Middle Aged Neoplasms, Multiple Primary - epidemiology Neoplasms, Multiple Primary - mortality Neoplasms, Second Primary - epidemiology Neoplasms, Second Primary - etiology Neoplasms, Second Primary - mortality Prevalence Retrospective Studies Survival Rate Tertiary Care Centers - statistics & numerical data Young Adult |
Title | Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34673592 https://search.proquest.com/docview/2584435053 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6ISFe0PguA2QknmCBfLlpeKtopw11A2kd2ltkO04X0SbS0k7an-I3cq8_kgBCGg-8RG2k3Ko9p9fn2tfHhLwJIDHKIsm9MahzLxZh4IkRTz0VhDJWUBWl2vHm6Cw5vRhPZ_FsMHBm_t29_4o03AOscefsP6DdBoUb8BowhyugDtdb4T7FP22FhsTaOdN0udVSah8mM2MOH7vGJuQOmcY1cTZbSB3XRqBay1W7_63Byhk9BYw7xRr0-1Kf7NuYze3Mu0FPIJx6WKERietBUK2XsonT7ZVZtY7OfYV8XGmzhJ6jBR6abJyikKbrsrOOcmz5xvMlr6vvrln8sty8m1yXFW-6yW5-w3XiP9OlB3YjrctNOyZNa320FebRS3jqSuV5G31aLrEP3fQ9zJVa8f5USRi0TXcw0tlJzyT2WGBXgmz-Ny7qludxL5knZku21QWJGa1-H3LiwEfri-PPX0_e4yXDE0ez0O_GV9dTcPolOzyfz7PF7GKxQ-6EkBnbOQAjHaAWZJFZesewH_4I-qt4-ktFpJXRYo_ctyUNnRguPiADVT0kd09s08Yj8sNRkjpK0rqgHSUPqCEk7RPygAIdqaMjPuDoSJFG1NCRWjrSHh0_0gk1ZKSGjLQlI-3IaKIYMmL0joyPyfnhbPHpyLPHhHgSanff43nK08JPx-NAqoCzVCWKh0Lhon6SowEfqGpVBHIUJbkAjSoFmj7FKahbNopE9ITsVnWlnhHKRnIUFKEULOYxT5nwRSFEyiSDt0lRDMlb9_tn9gsCNBmClWmc-mANyWuHUAY5GxfieKXqbZOFoPqhTIHxb0ieGujacBEol4il4fNbPL1P7nU0f0F2N1db9ZLsNPn2lebVT_FmyzA |
link.rule.ids | 315,782,786,866,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distinct+patterns+of+occurrence%2C+common+associations%2C+and+survival+of+patients+with+second+primary+maligancies%3A+A+5-year+single+institute+experience+with+review+of+literature&rft.jtitle=Indian+journal+of+pathology+%26+microbiology&rft.au=Vadgaonkar%2C+Rohit+Avinash&rft.au=Nayak%2C+Sonali+Susmita&rft.au=Doni%2C+Subhashreddy&rft.au=Digumarti%2C+Leela&rft.date=2021-10-01&rft.eissn=0974-5130&rft.volume=64&rft.issue=4&rft.spage=725&rft.epage=731&rft_id=info:doi/10.4103%2FIJPM.IJPM_1055_20&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0377-4929&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0377-4929&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0377-4929&client=summon |